Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akero Therapeutics Inc buy Cantor Fitzgerald

Akero Therapeutics Inc
Start price
€46.97
10.12.25 / 50%
Target price
-
10.12.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 10.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time.
Performance without dividends (%)
Name 1w
Akero Therapeutics Inc -
iShares Core DAX® 0.734%
iShares Nasdaq 100 -2.686%
iShares Nikkei 225® -2.261%
iShares S&P 500 -1.346%

Comments by Cantor_Fitzgerald for this prediction

In the thread Akero Therapeutics Inc diskutieren

Akero Therapeutics (NASDAQ:AKRO) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for AKRO provided by MarketBeat

Cantor Fitzgerald 
0
Report Share
10.12.25 Buy -

Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc

buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€20.34
20.06.24
-
20.06.25
131.22%
21.06.25

Cantor Fitzgerald 
20.06.24 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€23.57
12.06.24
-
12.06.25
96.48%
13.06.25

Cantor Fitzgerald 
12.06.24 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€13.80
11.10.23
€36.75
11.10.24
95.65%
12.10.24

Cantor Fitzgerald 
11.10.23 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€43.60
04.10.23
€65.81
04.10.24
-41.47%
05.10.24

Cantor Fitzgerald 
04.10.23 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€48.20
19.09.23
€64.47
19.09.24
-48.36%
20.09.24

Cantor Fitzgerald 
19.09.23 50%